Longbing Ling
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
- Biomaterials 14
- Nanoparticle-Based Drug Delivery 13
-
- RNA Interference and Gene Delivery 11
- Lipid Membrane Structure and Behavior 6
- Retinoids in leukemia and cellular processes 2
- Co-authors
- Xinsong Li (17 shared papers)Yawei Du (15 shared papers)Muhammad Ismail (16 shared papers)Chen Yao (14 shared papers)Qing You Xia (6 shared papers)Yuan Du (3 shared papers)Jianing Zhao (3 shared papers)Zhenglin Fu (4 shared papers)
- Journals
- International Journal of Pharmaceutics (6 papers)Colloids and Surfaces B Biointerfaces (4 papers)Journal of Drug Delivery Science and Technology (2 papers)European Journal of Pharmaceutical Sciences (2 papers)Nanomedicine (1 paper)
- Partner nations
- ChinaBangladeshUnited States
In The Last Decade
Longbing Ling
28 papers receiving 733 citations
Peers
Comparison fields: 5 of 93
- Biomaterials 276
- Pharmaceutical Science 70
- Molecular Medicine 29
- Molecular Biology 310
- Biomedical Engineering 199
Countries citing papers authored by Longbing Ling
This map shows the geographic impact of Longbing Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longbing Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longbing Ling more than expected).
Fields of papers citing papers by Longbing Ling
This network shows the impact of papers produced by Longbing Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longbing Ling. The network helps show where Longbing Ling may publish in the future.
Co-authors
The 25 scholars most cited alongside Longbing Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 74 | |
| 2 | 2018 | 73 | |
| 3 | 2018 | 55 | |
| 4 | 2019 | 52 | |
| 5 | 2022 | 45 | |
| 6 | 2022 | 42 | |
| 7 | 2019 | 41 | |
| 8 | 2017 | 38 | |
| 9 | 2017 | 31 | |
| 10 | 2021 | 30 | |
| 11 | 2023 | 29 | |
| 12 | 2019 | 28 | |
| 13 | 2018 | 25 | |
| 14 | 2020 | 21 | |
| 15 | 2021 | 20 | |
| 16 | 2019 | 19 | |
| 17 | 2017 | 18 | |
| 18 | 2018 | 17 | |
| 19 | 2019 | 17 | |
| 20 | 2017 | 14 |
About Longbing Ling
Longbing Ling is a scholar working on Biomaterials, Molecular Biology, Biomedical Engineering, Molecular Medicine and Polymers and Plastics, having authored 29 papers that have together received 741 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (13 papers), RNA Interference and Gene Delivery (11 papers), Nanoplatforms for cancer theranostics (7 papers), Lipid Membrane Structure and Behavior (6 papers), Dendrimers and Hyperbranched Polymers (3 papers), Malaria Research and Control (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers) and Retinoids in leukemia and cellular processes (2 papers). The work is most often cited by research in Biomaterials (276 citations), Pharmaceutical Science (70 citations), Molecular Medicine (29 citations), Molecular Biology (310 citations) and Biomedical Engineering (199 citations). Longbing Ling has collaborated with scholars based in China, Bangladesh and United States. Frequent co-authors include Xinsong Li, Yawei Du, Muhammad Ismail, Chen Yao, Qing You Xia, Yuan Du, Jianing Zhao, Zhenglin Fu, Wenya Zhou and Leiming Zhang. Their work appears in journals such as International Journal of Pharmaceutics, Colloids and Surfaces B Biointerfaces, Journal of Drug Delivery Science and Technology, European Journal of Pharmaceutical Sciences and Nanomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.